8.65新台幣0.16(1.89%)
2022/08/10更新
績效 / 1月3.97%
3月6.27%
1年26.76%
晨星評等-
淨值走勢
持股明細 / 風險評估
- 1.美國41.25%
- 2.新興亞洲10.74%
- 3.歐洲不包含歐元區8.95%
- 4.歐元區8.81%
- 5.日本8.50%
- 1.周期性消費45.64%
- 2.健康護理31.06%
- 3.防守性消費2.82%
- 1.Novo Nordisk A/S Class B8.95%
- 2.Edwards Lifesciences Corp8.51%
- 3.Nike Inc Class B7.40%
- 4.Li Ning Co Ltd6.27%
- 5.ResMed Inc4.99%
- 1.美國41.25%
- 2.新興亞洲10.74%
- 3.歐洲不包含歐元區8.95%
- 4.歐元區8.81%
- 5.日本8.50%
- 1.Novo Nordisk A/S Class B8.95%
- 2.Edwards Lifesciences Corp8.51%
- 3.Nike Inc Class B7.40%
- 4.Li Ning Co Ltd6.27%
- 5.ResMed Inc4.99%
- 1.周期性消費45.64%
- 2.健康護理31.06%
- 3.防守性消費2.82%